ReShape Lifesciences Inc. (RSLS), on Thursday announced it has entered into an exclusive U.S. distribution agreement with Recon Supply to expand access to its medical device portfolio across the Veterans Administration or VA and Department of Defense or DoD healthcare systems.
Under the agreement, Recon Supply becomes the exclusive distributor of ReShape's full product line, including the FDA-cleared STIMEL-03 neuromuscular rehabilitation device and the next-generation Lap-Band 2.0 FLEX system, to VA and DoD medical facilities.
The partnership aims to broaden the availability of clinically proven technologies to more than 18 million U.S. veterans and active-duty service members.
Recon Supply, a Service-Disabled Veteran-Owned Small Business or SDVOSB, currently distributes to 102 VA Medical Centers and holds federal contracts such as DAPA, FSS, and ECAT, which enable streamlined procurement across government health systems.
STIMEL-03 is a neurorehabilitation device that combines real-time EMG biofeedback with personalized electrical stimulation, designed to support recovery from stroke, surgery, or injury.
The Lap-Band 2.0 FLEX provides a minimally invasive, adjustable weight-loss option and is part of ReShape's broader portfolio of solutions targeting obesity and metabolic disorders.
"This agreement with Recon Supply marks a pivotal step forward in ReShape's mission to expand access to innovative medical technologies that improve lives," said Paul F. Hickey, President and CEO of ReShape Lifesciences.
He added that, "Through Recon's established federal presence, we can now deliver our leading-edge devices to veterans and military personnel across the country.
Currently, RSLS is trading at $3.49, up by 55.91 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.